EXOME

all the information, none of the junk | biotech • healthcare • life sciences

$30M Series F for EndoGastric

EndoGastric Solutions in Redwood City, CA, said today that it has raised $30 million in Series F financing to support development and marketing of its devices for incisionless surgery to treat acid reflux and other gastrointestinal conditions. Canaan Partners and Radius Ventures led the round, which was joined by existing investors Advanced Technology Ventures, MPM Capital, Foundation Medical Partners, Chicago Growth Partners, and De Novo Ventures.